Ex-vivo Examination of Excisions of Skin Tumors by Confocal Optical Coherence Tomography (LC-OCT) With Integrated Dermoscopy and Comparison With Histology (DERMOCTAV)
Launched by RAMSAY GÉNÉRALE DE SANTÉ · Apr 15, 2022
Trial Information
Current as of June 29, 2025
Unknown status
Keywords
ClinConnect Summary
There are mainly 3 types of skin cancer: melanoma, basal cell carcinoma and squamous cell carcinoma. The diagnosis of skin cancers is now based on anatomo-pathological evidence. However, given the progress made, imaging is a technique that now has a full role in the diagnosis of these pathologies. This is particularly the case of confocal optical coherence tomography (LC-OCT), which is a recent imaging technique that has proven itself in ophthalmology with the obtaining of precise images of the retina.
LC-OCT can be applied in dermatology according to the following principle: the low inten...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient, male or female, at least 18 years old
- • Patient with a skin lesion suspected of a cancerous pathology (basal cell carcinoma - BCC, squamous cell carcinoma - SCC and melanoma) and for whom surgery is planned at Antony Hospital
- • Affiliated patient or beneficiary of a social security scheme
- • Patient having signed the free and informed consent
- Exclusion Criteria:
- • Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
- • Pregnant or breastfeeding women
- • Patient hospitalized without consent
About Ramsay Générale De Santé
Ramsay Générale de Santé is a leading private healthcare provider in France, dedicated to delivering high-quality medical services and advancing healthcare through innovative clinical research. With a robust portfolio of hospitals and clinics, the organization focuses on improving patient outcomes by conducting rigorous clinical trials across various therapeutic areas. Committed to enhancing healthcare solutions, Ramsay Générale de Santé collaborates with healthcare professionals, researchers, and pharmaceutical companies to facilitate groundbreaking studies that contribute to medical knowledge and patient care advancements. Their emphasis on patient safety, ethical standards, and scientific integrity underscores their role as a trusted sponsor in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Antony, Idf, France
Patients applied
Trial Officials
DRE RAMSAYGDS
Study Chair
Ramsay Générale de Santé
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials